The week’s best buys

Convatec The Times

This medical products specialist, with leading market positions in wound and ostomy care, was rapidly promoted to the FTSE 100 after floating last year. Driven by demographics, it is cash generative and set to beat growth forecasts. Buy. 295p.

Moss Bros Group Investors Chronicle

The gents’ outfitter continues to defy the gloomy high street: its 127-unit shop estate operates on flexible, short-term leases. Expanding online and internationally. Yields 6.5%. Buy. 100p.

Rentokil Initial The Times

The pest control specialist’s broad portfolio includes insurance, plant rental and hygiene businesses. Profits have doubled in five years thanks to global expansion. Shares aren’t cheap, but should go higher. Buy. £2.50.

Sage Group The Times

The software firm, known for its “dull reliability”, is selling its US payments business. Future growth looks assured and there is a promising move into cloud-based products. Cost savings are boosting margins. Buy. 707p.

Telecom Plus The Daily Telegraph

This multi-utility energy firm is well set to benefit from any government crackdown on energy prices. Competitive tariffs, bundled services and a new home insurance offer should boost earnings momentum. Buy. £12.50.

Venture Life Group The Mail on Sunday

Venture Life makes medically approved products for the fast-growing “wellness” market, including Ultradex mouthwash and skincare. Targeting the over-40s, and expanding. Profits should rise rapidly. Buy. 58.5p.